Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2026-04-04 @ 6:41 AM
Study NCT ID:
NCT00022932
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2001-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP
Sponsor:
Corixa Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CP-99-032
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None